Haleon PLC HLNCF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HLNCF is a good fit for your portfolio.
News
-
GSK Sells Last Haleon Shares for $1.58 Billion
-
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion — Update
-
GSK to Sell Stake in Haleon Valued at About $1.61 Billion
-
Haleon to Cut 435 Jobs, Shut U.K. Production Site
-
Haleon Taps Tate & Lyle Finance Chief Dawn Allen as CFO
-
Repeat & Correct: Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale — Update
-
Pfizer to Cut Stake in Haleon — Update
-
Pfizer to Cut Stake in Haleon to 24%
Trading Information
- Previous Close Price
- $4.18
- Day Range
- $4.16–4.16
- 52-Week Range
- $3.81–4.36
- Bid/Ask
- $0.01 / $91,204.20
- Market Cap
- $37.94 Bil
- Volume/Avg
- 1,087 / 56,224
Key Statistics
- Price/Earnings (Normalized)
- 18.08
- Price/Sales
- 2.72
- Dividend Yield (Trailing)
- 1.81%
- Dividend Yield (Forward)
- 1.81%
- Total Yield
- 1.81%
Company Profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 25,408
- Website
- https://www.haleon.com
Competitors
Valuation
|
Metric
|
HLNCF
|
RKT
|
PG
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.08 | 10.14 | 25.66 |
Price/Book Value | 1.81 | 3.88 | 8.03 |
Price/Sales | 2.72 | 2.26 | 4.93 |
Price/Cash Flow | 17.17 | 12.20 | 20.44 |
Price/Earnings
HLNCF
RKT
PG
Financial Strength
|
Metric
|
HLNCF
|
RKT
|
PG
|
|---|---|---|---|
Quick Ratio | 0.63 | 0.40 | 0.40 |
Current Ratio | 1.04 | 0.64 | 0.64 |
Interest Coverage | 4.94 | 9.00 | 20.66 |
Quick Ratio
HLNCF
RKT
PG
Profitability
|
Metric
|
HLNCF
|
RKT
|
PG
|
|---|---|---|---|
Return on Assets (Normalized) | — | 8.60% | 13.82% |
Return on Equity (Normalized) | — | 26.61% | 35.61% |
Return on Invested Capital (Normalized) | — | 14.24% | 20.62% |
Return on Assets
HLNCF
RKT
PG
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Gxlqpkhvtp | Yncn | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Cdlhwgvm | Qmtcnfg | $79.0 Bil | |
HLN
| Haleon PLC ADR | Dttzlmztr | Fpmnj | $38.5 Bil | |
VTRS
| Viatris Inc | Gdstffq | Xjfc | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wvwtzmqj | Lkm | $11.7 Bil | |
CTLT
| Catalent Inc | Rckybmp | Hzflthh | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Khjlcqzg | Fsrj | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Qssksfqn | Lmp | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ltxmhfwd | Dnyzgv | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Mbswgwtj | Knhf | $3.1 Bil |